| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Microbiology, School of Medicine, University of Washington, Seattle, Washington 98195
The 3645-base pair human topoisomerase I complementary DNA (cDNA) clone isolated by D'Arpa et al. (Proc. Natl. Acad. Sci. USA, 85: 2543–2547, 1988) and a mutated version of the cDNA encoding a protein with phenylalanine instead of tyrosine at position 723 have been overexpressed 2- to 5-fold in stably transfected baby hamster kidney cells. The overexpressed proteins are the same size as the topoisomerase I present in Hela cells, indicating that the cDNA clone contains the complete topoisomerase I coding sequence. Some human colon carcinoma cells have increased levels of topoisomerase I and are hypersensitive to the drug camptothecin. The overexpressed wild-type topoisomerase I does not affect the cell growth or morphology of the baby hamster kidney cells, suggesting that elevated levels of topoisomerase I alone are not sufficient to cause cell transformation. However, the overexpressed wild-type protein is active, as shown by the hypersensitivity of clonal cell lines to camptothecin. The mutant form of topoisomerase I is enzymatically inactive by two criteria. First, extracts of Escherichia coli cells carrying the mutant cDNA contain no activity capable of relaxing superhelical DNA under conditions where activity is easily detectable in extracts from cells containing the wild-type cDNA. Second, baby hamster kidney cells stably transfected by the mutant cDNA are no more sensitive to camptothecin than control untransfected cells. These results indicate that tyrosine 723 is essential for enzyme activity and are consistent with predictions based on homology comparisons with the yeast enzymes, that this is the active-site tyrosine in the human topoisomerase I.
1 Supported by Grant DMB-8917877 from the National Science Foundation.
2 To whom requests for reprints should be addressed, at Department of Microbiology SC-42, University of Washington, Seattle, WA 98195.
Received 7/ 9/91. Accepted 11/11/91.
This article has been cited by other articles:
|
|
 |
|
  J. S. Hackbarth, M. Galvez-Peralta, N. T. Dai, D. A. Loegering, K. L. Peterson, X. W. Meng, L. M. Karnitz, and S. H. Kaufmann Mitotic Phosphorylation Stimulates DNA Relaxation Activity of Human Topoisomerase I J. Biol. Chem., June 13, 2008; 283(24): 16711 - 16722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ganguly, B. B. Das, N. Sen, A. Roy, S. B. Dasgupta, and H. K. Majumder 'LeishMan' topoisomerase I: an ideal chimera for unraveling the role of the small subunit of unusual bi-subunit topoisomerase I from Leishmania donovani Nucleic Acids Res., December 4, 2006; 34(21): 6286 - 6297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-A. Bjornsti Cellular Responses to Replication Stress: Lessons from Yeast Am. Assoc. Cancer Res. Educ. Book, April 1, 2005; 2005(1): 250 - 253. [Full Text] [PDF]
|
|
|
|
|
|
D. Yu, E. Khan, M. A. Khaleque, J. Lee, G. Laco, G. Kohlhagen, S. Kharbanda, Y.-C. Cheng, Y. Pommier, and A. Bharti Phosphorylation of DNA Topoisomerase I by the c-Abl Tyrosine Kinase Confers Camptothecin Sensitivity J. Biol. Chem., December 10, 2004; 279(50): 51851 - 51861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Gurevich, P. D. Aplan, and R. K. Humphries NUP98-Topoisomerase I acute myeloid leukemia-associated fusion gene has potent leukemogenic activities independent of an engineered catalytic site mutation Blood, August 15, 2004; 104(4): 1127 - 1136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. CHAMPOUX Structure-Based Analysis of the Effects of Camptothecin on the Activities of Human Topoisomerase I Ann. N.Y. Acad. Sci., December 1, 2000; 922(1): 56 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. FIORANI and M.-A. BJORNSTI Mechanisms of DNA Topoisomerase I-Induced Cell Killing in the Yeast: Saccharomyces cerevisiae Ann. N.Y. Acad. Sci., December 1, 2000; 922(1): 65 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Rizou, J. P. A. Ioannidis, E. Panou-Pomonis, M. Sakarellos-Daitsiotis, C. Sakarellos, H. M. Moutsopoulos, and P. G. Vlachoyiannopoulos B-Cell Epitope Mapping of DNA Topoisomerase I Defines Epitopes Strongly Associated with Pulmonary Fibrosis in Systemic Sclerosis Am. J. Respir. Cell Mol. Biol., March 1, 2000; 22(3): 344 - 351. [Abstract] [Full Text]
|
|
|
|
|
|
L. Stewart, G. C. Ireton, and J. J. Champoux A Functional Linker in Human Topoisomerase I Is Required for Maximum Sensitivity to Camptothecin in a DNA Relaxation Assay J. Biol. Chem., November 12, 1999; 274(46): 32950 - 32960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W. Trowbridge, R. Roy, and D. T. Simmons Human Topoisomerase I Promotes Initiation of Simian Virus 40 DNA Replication In Vitro Mol. Cell. Biol., March 1, 1999; 19(3): 1686 - 1694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. T. Simmons, R. Roy, L. Chen, D. Gai, and P. W. Trowbridge The Activity of Topoisomerase I Is Modulated by Large T Antigen during Unwinding of the SV40 Origin J. Biol. Chem., August 7, 1998; 273(32): 20390 - 20396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Hann, D. L. Evans, J. Fertala, P. Benedetti, M.-A. Bjornsti, and D. J. Hall Increased Camptothecin Toxicity Induced in Mammalian Cells Expressing Saccharomyces cerevisiae DNA Topoisomerase I J. Biol. Chem., April 3, 1998; 273(14): 8425 - 8433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Redinbo, L. Stewart, P. Kuhn, J. J. Champoux, and W. G. Hol Crystal Structures of Human Topoisomerase I in Covalent and Noncovalent Complexes with DNA Science, March 6, 1998; 279(5356): 1504 - 1513. [Abstract] [Full Text]
|
|
|
|
|
|
L. Stewart, M. R. Redinbo, X. Qiu, W. G. Hol, and J. J. Champoux A Model for the Mechanism of Human Topoisomerase I Science, March 6, 1998; 279(5356): 1534 - 1541. [Abstract] [Full Text]
|
|
|
|
|
|
M. D. Megonigal, J. Fertala, and M.-A. Bjornsti Alterations in the Catalytic Activity of Yeast DNA Topoisomerase I Result in Cell Cycle Arrest and Cell Death J. Biol. Chem., May 9, 1997; 272(19): 12801 - 12808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Cheng, L. K. Wang, J. Sekiguchi, and S. Shuman Mutational Analysis of 39Residues of Vaccinia DNA Topoisomerase Identifies Lys-220, Arg-223, and Asn-228 as Important for Covalent Catalysis J. Biol. Chem., March 28, 1997; 272(13): 8263 - 8269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. O. Petersen and S. Shuman Histidine 265Is Important for Covalent Catalysis by Vaccinia Topoisomerase and Is Conserved in All Eukaryotic Type I Enzymes J. Biol. Chem., February 14, 1997; 272(7): 3891 - 3896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B M Shykind, J Kim, L Stewart, J J Champoux, and P A Sharp Topoisomerase I enhances TFIID-TFIIA complex assembly during activation of transcription. Genes & Dev., February 1, 1997; 11(3): 397 - 407. [Abstract] [PDF]
|
|
|
|
|
|
L. Stewart, G. C. Ireton, L. H. Parker, K. R. Madden, and J. J. Champoux Biochemical and Biophysical Analyses of Recombinant Forms of Human Topoisomerase I J. Biol. Chem., March 29, 1996; 271(13): 7593 - 7601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Stewart, G. C. Ireton, and J. J. Champoux The Domain Organization of Human Topoisomerase I J. Biol. Chem., March 29, 1996; 271(13): 7602 - 7608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Froelich-Ammon and N. Osheroff Topoisomerase Poisons: Harnessing the Dark Side of Enzyme Mechanism J. Biol. Chem., September 15, 1995; 270(37): 21429 - 21432. [Full Text] [PDF]
|
|
|
|
|
|
G. C. Ireton, L. Stewart, L. H. Parker, and J. J. Champoux Expression of Human Topoisomerase I with a Partial Deletion of the Linker Region Yields Monomeric and Dimeric Enzymes That Respond Differently to Camptothecin J. Biol. Chem., August 11, 2000; 275(33): 25820 - 25830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Yang and J. J. Champoux The Role of Histidine 632 in Catalysis by Human Topoisomerase I J. Biol. Chem., January 5, 2001; 276(1): 677 - 685. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
